IRVINE, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- via IBN -- ECGI Holdings Inc. (OTC:ECGI) Dear Shareholders, Partners, and Friends, When I first stepped into the role of CEO back in May, ECGI Holdings held two foundational assets: Pacific Saddlery, a premium equestrian apparel and equipment brand in a $17.5 billion global market, and Vintner's Caldera Ranch, a five acre vineyard and short term rental property in Lake County, California, participating in the $121 billion hospitality and vacation rental sec ...

Live Presentation to be Webcast Today at 9am ETHINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, today announced that Harel Gadot, CEO, President & Chairman, will highlight the recent FDA clearance of the LIBERTY® System, the first single-use, remotely operated robotic system for peripheral endovascular procedures, at the H.C. Wainwright Annual Investor Conference. The Company’s presenta ...

公司财务信息 - 将于2025年9月24日美东时间上午8:30举行第一季度财报电话会议 [1] - 2025财年第一季度业绩将在9月23日市场收盘后公布 [1] 投资者关系安排 - 可通过公司官网IR.worthingtonenterprises.com注册参加9月24日音频网络直播 [2] - 电话会议回放将在结束后约两小时提供 并存档一年 [2] - 电话会议ID为1777337 美国境内参与者可拨打888-330-3567 [3] 公司业务概况 - 公司运营两大业务板块：建筑产品和消费产品 [4] - 建筑产品板块包括暖通空调组件 建筑声学吊顶系统及金属框架配件 [4] - 消费产品板块涵盖工具 户外生活和庆典用品类别 [4] - 旗下品牌包含Balloon Time Bernzomatic Coleman等知名品牌 [4] 公司基本数据 - 总部位于俄亥俄州哥伦布市 在北美和欧洲拥有约6000名员工 [5] - 公司前身为1955年成立的沃辛顿工业 采用以人为本的经营理念 [6] - 通过沃辛顿基金会参与社区志愿服务和劳动力发展项目 [6]

Additional patent granted from the Japanese patent office now results in 20 granted patents and allowed applications covering the compound and its underlying technology SOUTH SAN FRANSCISCO, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative cellular immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces the Company received a Notice of Allowan ...

文章核心观点 - VCI Global子公司Smart Bridge Technologies推出专注于现实世界资产（RWA）代币化的咨询业务 旨在抓住规模达16万亿美元的代币化市场机会 通过整合人工智能、资本市场咨询和区块链技术 增强公司跨行业平台能力 并实现收入多元化和利润率提升 [1][2][3] 业务战略扩展 - 新业务是公司跨行业平台战略的自然延伸 整合了资本市场咨询、人工智能、金融科技和网络安全能力 通过代币化服务连接传统金融与数字资产 [2][3] - 具体服务包括资产代币化咨询（涵盖房地产、大宗商品、碳信用、知识产权及私募股权）、受监管上市支持（新加坡、香港和美国市场）、跨境资本接入以及技术集成解决方案 [7] - 通过为资产密集型行业提供替代融资方案 生成经常性高利润率收入 并通过端到端生命周期支持深化客户关系 [8] 市场机会与定位 - 目标市场规模达16万亿美元 由波士顿咨询集团和ADDX预测 [1] - 通过将实体和金融资产转换为区块链验证的可交易工具 为客户提供新流动性渠道、透明度和全球投资者接入机会 [2] - 公司定位为金融市场创新前沿 特别专注于东南亚地区政府、企业和机构的数字化生态建设 [6][7] 技术能力与竞争优势 - Smart Bridge结合人工智能创新与资本市场洞察 提供端到端解决方案 专注于AI驱动的自动化、企业级IT解决方案和数字化转型服务 [4][5] - 采用专有军事级加密技术 满足数字主权、国家安全和企业韧性的最高标准 [9] - 子公司具备软件开发、系统集成和数字咨询的专业能力 并与区块链赋能的金融解决方案相结合 [4]

Charlotte, NC, Sept. 09, 2025 (GLOBE NEWSWIRE) -- FG Nexus Inc. (Nasdaq: FGNX, FGNXP) (the “Company”), today announced that its Board of Directors has approved a Share repurchase program to acquire up to $200 million of the Company's outstanding common stock (the “Share Repurchase Program”). The Stock Repurchase Program, which is open-ended, allows the Company to repurchase its shares from time to time in the open market and in negotiated transactions. Any repurchases conducted pursuant to the Share Repurch ...

New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFoods® IBS testingIBS affects an estimated 40 million adults in the U.S. and hundreds of millions worldwide IRVINE, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic and therapeutic solutions, today announced the launch of its inFoods® IBS Trigger Food Navigator, a comprehensive AI-backed digital companion tool designed ...

Highlighting Continued Progress with EMA Regarding a Potential Conditional Marketing Authorization Submission for Iopofosine I 131 to Treat Waldenstrom Macroglobulinemia (WM) in the EU; Decision on Track for Late 3Q25/Early 4Q25 Intention to Pursue an Accelerated Approval with the U.S. Food and Drug Administration for Iopofosine I 131 as a Treatment for WM Advancing Auger-Emitting Radiopharmaceutical Product Candidate into Phase 1b Clinical Trial for the Treatment of Triple-Negative Breast Cancer in 4Q25 FL ...

DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, analyses Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, appointment of Kenneth Le as Managing Director of Prodigy Silk Ltd, the Company’s wholly owned recombinant spider silk production subsidiary in Southeast Asia. The strategic promotion of Le comes at a pivota ...

NKGen acquires controlling stake in NKMax, marking a pivotal moment in its transformation into a fully integrated, self-sustaining, cell therapy company with global manufacturing and IP control.Approximately $16.9 million paid to acquire 65% equity stake in recapitalized debt-free NKMax, with NKMax operations now expected to be funded through 2026.Funding provided by AlpineBrook Capital GP 1 Limited and NKGen CEO Dr. Paul Y. Song. SANTA ANA, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OT ...